
Free Daily Podcast Summary
by Oncololgy News Central
Peer-Spectives is a podcast series that is moderated by Robert Figlin, MD, and features various oncology thought-leaders covering the latest clinical developments in a wide range of tumor types.
The most recent episodes — sign up to get AI-powered summaries of each one.
Recording live at the 2026 World Conference on Lung Cancer (WCLC) in Seoul, South Korea, Estelamari Rodriguez, MD, MPH, from the Sylvester Comprehensive Cancer Center at the University of Miami, speaks with Wade Iams, MD, from Tennessee Oncology in Nashville, and Luis Raez, MD, from Memorial Cancer Institute in Miami, Forida, about selecting first-line combination therapy and managing amivantamab plus lazertinib in clinical practice.
At WCLC 2026, three thoracic oncologists discuss first-line combinations, toxicity management, and subcutaneous amivantamab.
The dramatic increase in cancer survivorship is introducing questions about the ability of physicians to meet patient needs. “Maybe we need to have a survivor cancer patient see a survivorship physician,” Robert Figlin, MD, discusses with Sunita Puri, MD.
Advances in cancer treatments have led to a rising “tsunami” of survivors, which has introduced a new set of challenges for oncologists. Saro H. Armenian, DO, MPH, discusses what changes are needed across oncology with Robert A. Figlin, MD.
Amid the exciting advances at ASCO 2026, there came a “sobering moment” regarding the U.S.’s role as a cancer clinical trial leader, says Robert A. Winn, MD. He discusses what this means for cancer centers going forward with Robert A. Figlin, MD.
The prospective randomized NHS-Galleri multicancer early detection trial didn’t meet its primary endpoint, but it did uncover a lot more early-stage cancers than predicted. Eric Klein, MD, and Robert Figlin, MD, talk about what the data reveal about cancer biology and for screening programs.
Data presented at the 2026 American Society of Clinical Oncology Annual Meeting add to the “ever-shifting and chaotic space” that is CLL care, says Matthew Lunning, DO. He discusses how new findings are affecting practice with Robert A. Figlin, MD.
New treatments for patients with microsatellite instability–high colorectal cancer are drastically changing outcomes. Nicholas James Hornstein, MD, PhD, discusses recent advances and key findings from the 2026 American Society of Clinical Oncology Annual Meeting with Carolina Bernabe Ramirez, MD
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
Listeners also like.

INTERLUDE: Cancer Stories with Dr. Teplinsky
Eleonora Teplinsky

Out of the Gray (Gy) - Standard Imaging
Conversations with experts in radiation oncology exploring advancements in technology, research, and clinical practice.

In the Interim...
Explores Bayesian statistics and adaptive clinical trial designs in medical research with insights from industry experts.

Thrive Through and Beyond Cancer
Season Johnson

ICU Ed and Todd-Cast
Eddie and Todd

Frankly Speaking About Family Medicine
Discusses current topics and developments in primary care and family medicine.

Health Matters
NewYork-Presbyterian

This Week in Cardiology
A weekly summary and analysis of key developments in cardiology for healthcare professionals.

The Peter Attia Drive
Conversations with experts on health, longevity, performance, and critical thinking led by physician Peter Attia.

The Curbsiders Internal Medicine Podcast
Expert-led internal medicine discussions with clinical insights and humor for primary care and hospital medicine providers.

CSPI Podcast
Conversations with CSPI scholars and experts on topics in science, technology, and politics.

Get Better Faster
Doctors and researchers discuss functional medicine and root-cause approaches to chronic illness and health optimization.
Peer-Spectives is a podcast series that is moderated by Robert Figlin, MD, and features various oncology thought-leaders covering the latest clinical developments in a wide range of tumor types.
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from Oncology News Central Peer-Spectives in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of Oncology News Central Peer-Spectives as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Oncololgy News Central.
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
Oncology News Central Peer-Spectives publishes weekly. Our AI generates a summary within hours of each new episode.
Oncology News Central Peer-Spectives covers topics including Science. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.